- World rank, 2022–2025
- #24,513 of 28,054 · #36,889 all time
- Rank in China
- #3,027 of 3,058
- Research works
- 242 ▲ 83% vs 2013–17
- Citations
- 1.5k 6.1 per fractional work
- Top-10% rate
- 7.1% record average 16.5%
- Open access
- 32% world 28%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Veterinary, 14.3×. Every wedge is a field page.
- Veterinary 14.3×
- Immunology and Microbiology 6.2×
- Biochemistry, Genetics and Molecular Biology 5.9×
- Pharmacology, Toxicology and Pharmaceutics 3.9×
- Chemical Engineering 2.6×
- Medicine 2.2×
- Chemistry 1.2×
- Mathematics 1.2×
- Nursing 0.5×
- Computer Science 0.5×
- Engineering 0.4×
- Decision Sciences 0.2×
- Materials Science 0.2×
- Agricultural and Biological Sciences 0.2×
- Neuroscience 0.2×
- Business, Management and Accounting 0.1×
- Energy 0.1×
- Arts and Humanities 0.1×
- Health Professions 0.0×
- Social Sciences 0.0×
Who are the top researchers at Crown Bioscience (China)?
Ranked on the composite score, Qian Shi and Sheng Guo lead among researchers whose main affiliation is Crown Bioscience (China).
- 1 Qian Shi China · #1,225,160 worldwide 11 citations · 24 works
- 2 Sheng Guo China · #1,289,302 worldwide 31 citations · 41 works
Which keywords describe research at Crown Bioscience (China)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Immunotherapy, Tumor Regression, Cancer Stem Cells, Tumor Metastasis, Cancer Immunotherapy, Tumor Microenvironment, Gene Expression and Targeted Therapy.
- Therapeutic Antibodies
- Molecular Docking
- Fc Receptors
- Protein-Protein Interaction Networks
- Gene Set Enrichment Analysis
- Angiogenesis
- Medicinal Chemistry
- Immunity
- PET Imaging
- Chimeric Antigen Receptor
- Bacterial Therapy
- Tissue Engineering
- Lymphoma
- Tumor Targeting
- Glycosylation
- Gene Expression
- Cancer
- Machine Learning
- Tumor Regression
- Cancer Stem Cells
- Immunotherapy
- Tumor Metastasis
- Cancer Immunotherapy
- Tumor Microenvironment
- Cell Culture
- Targeted Therapy
- Inflammation
- Gene Therapy
- Bioprinting
- Arginine Deprivation
- CAR T Cells
- Data Analysis
- Pharmacokinetics
- Normalization
- Prognostic Factors
- Cancer Genomics
- Mutational Signatures
- Monoclonal Antibodies
- Immune Checkpoint Blockade
- PD-1 and PD-L1
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Immunotherapy7▲ 13×6 topics
- Cancer Stem Cells6▲ 177×1 topic
- Tumor Metastasis6▲ 139×1 topic
- Tumor Regression6▲ 72×2 topics
- Cancer Immunotherapy5▲ 42×3 topics
- Machine Learning5▲ 1.98×6 topics
- Tumor Microenvironment4▲ 13×5 topics
- Cancer4▲ 4.2×10 topics
- Cell Culture4▲ 49×2 topics
- Gene Expression4▲ 9.1×5 topics
- Targeted Therapy4▲ 25×3 topics
- Glycosylation4▲ 48×3 topics
- Inflammation4▲ 2.5×11 topics
- Tumor Targeting4▲ 29×3 topics
- Gene Therapy4▲ 26×3 topics
- Lymphoma4▲ 30×2 topics
- Bioprinting3▲ 69×1 topic
- Tissue Engineering3▲ 6.8×1 topic
- Arginine Deprivation3▲ 110×1 topic
- Bacterial Therapy3▲ 110×1 topic
- CAR T Cells3▲ 53×1 topic
- Chimeric Antigen Receptor3▲ 53×1 topic
- Data Analysis3▲ 14×3 topics
- PET Imaging3▲ 22×3 topics
- Pharmacokinetics3▲ 14×3 topics
- Immunity2▲ 8.6×3 topics
- Normalization2▲ 69×2 topics
- Medicinal Chemistry2▲ 12×2 topics
- Prognostic Factors2▲ 7.5×5 topics
- Angiogenesis2▲ 9.9×4 topics
- Cancer Genomics2▲ 43×1 topic
- Gene Set Enrichment Analysis2▲ 93×1 topic
- Mutational Signatures2▲ 43×1 topic
- Protein-Protein Interaction Networks2▲ 93×1 topic
- Monoclonal Antibodies2▲ 34×2 topics
- Fc Receptors2▲ 51×1 topic
- Immune Checkpoint Blockade2▲ 25×1 topic
- Molecular Docking2▲ 22×1 topic
- PD-1 and PD-L12▲ 25×1 topic
- Therapeutic Antibodies2▲ 40×1 topic
Which research topics does Crown Bioscience (China) publish most on?
By volume in 2022–2025: Cancer Cells and Metastasis, 3D Printing in Biomedical Research, CAR-T cell therapy research and Cancer Research and Treatments.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Cancer Cells and Metastasis Oncology 6 works
- 2 3D Printing in Biomedical Research Biomedical Engineering 3 works
- 3 CAR-T cell therapy research Oncology 3 works
- 4 Cancer Research and Treatments Biotechnology 3 works
- 5 Bioinformatics and Genomic Networks Molecular Biology 2 works
- 6 Cancer Genomics and Diagnostics Cancer Research 2 works
- 7 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 2 works
- 8 Cancer Immunotherapy and Biomarkers Oncology 2 works
- 9 Computational Drug Discovery Methods Computational Theory and Mathematics 2 works
- 10 Molecular Biology Techniques and Applications Molecular Biology 2 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Crown Bioscience (China)'s research output changed?
Output in 2018–2022 was 83% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Beijing
- Chinese Academy of Sciences
- Tsinghua University
- Peking University
- University of Chinese Academy of Sciences
- Beihang University
- Beijing Institute of Technology
- Chinese Academy of Medical Sciences & Peking Union Medical College
- North China Electric Power University
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.